CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,972,000 | -42.5% | 1,377,298 | -1.9% | 0.00% | 0.0% |
| Q3 2016 | $8,651,000 | +66.5% | 1,404,398 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $5,196,000 | -28.3% | 1,404,398 | -2.4% | 0.00% | 0.0% |
| Q1 2016 | $7,251,000 | -37.3% | 1,438,668 | -1.3% | 0.00% | -50.0% |
| Q4 2015 | $11,556,000 | -2.2% | 1,457,298 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $11,815,000 | -33.5% | 1,460,498 | +0.3% | 0.00% | 0.0% |
| Q2 2015 | $17,774,000 | – | 1,455,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,857,667 | $4,572,000 | 5.05% |
| Clarus Ventures, LLC | 2,752,488 | $4,404,000 | 3.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 388,030 | $621,000 | 0.12% |
| Rhenman & Partners Asset Management AB | 310,756 | $497,000 | 0.08% |
| BOSTON FAMILY OFFICE LLC | 24,467 | $39,000 | 0.01% |
| OPPENHEIMER & CO INC | 90,000 | $144,000 | 0.00% |
| Alyeska Investment Group, L.P. | 221,281 | $354,000 | 0.00% |
| A.R.T. Advisors, LLC | 46,747 | $74,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 101,347 | $162,000 | 0.00% |
| Acrospire Investment Management LLC | 680 | $1,000 | 0.00% |